Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine the safety of pemetrexed and any side effects
that might be associated with it, whether pemetrexed can help patients with breast cancer and
how much pemetrexed should be given to patients.